LAVA Therapeutics N.V. (LVTX) Tops Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts LVTX Hot Sheet
Join SI Premium – FREE
LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q3 EPS of ($0.34), $0.15 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- Innovaro (INV) Misses Q2 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
